'TAG'
(id=10984927 ; fe=TAG ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=2552 creation date=2018-05-12 touchdate=2025-07-15 16:15:10.000) ≈ 18 relations sortantes
- TAG --
r_associated #0: 39 / 1 ->
triacylglycérides
n1=TAG | n2=triacylglycérides | rel=r_associated | relid=0 | w=39
- TAG --
r_associated #0: 35 / 0.897 ->
Techniques d'Amplification Génique
n1=TAG | n2=Techniques d'Amplification Génique | rel=r_associated | relid=0 | w=35
- TAG --
r_associated #0: 35 / 0.897 ->
triacylglycérols
n1=TAG | n2=triacylglycérols | rel=r_associated | relid=0 | w=35
- TAG --
r_associated #0: 34 / 0.872 ->
en:GAD
n1=TAG | n2=en:GAD | rel=r_associated | relid=0 | w=34
- TAG --
r_associated #0: 30 / 0.769 ->
triglycérides
n1=TAG | n2=triglycérides | rel=r_associated | relid=0 | w=30
- TAG --
r_associated #0: 28 / 0.718 ->
en:triglyceride
n1=TAG | n2=en:triglyceride | rel=r_associated | relid=0 | w=28
- TAG --
r_associated #0: 27 / 0.692 ->
glycérides
n1=TAG | n2=glycérides | rel=r_associated | relid=0 | w=27
- TAG --
r_associated #0: 21 / 0.538 ->
Tafeen (cathéter de)
n1=TAG | n2=Tafeen (cathéter de) | rel=r_associated | relid=0 | w=21
- TAG --
r_associated #0: 20 / 0.513 ->
en:triglycerides
n1=TAG | n2=en:triglycerides | rel=r_associated | relid=0 | w=20
- TAG --
r_associated #0: 20 / 0.513 ->
McLaren-TAG
n1=TAG | n2=McLaren-TAG | rel=r_associated | relid=0 | w=20
- TAG --
r_associated #0: 20 / 0.513 ->
TAG-Porsche
n1=TAG | n2=TAG-Porsche | rel=r_associated | relid=0 | w=20
- TAG --
r_associated #0: 20 / 0.513 ->
techniques d'amplification génique
n1=TAG | n2=techniques d'amplification génique | rel=r_associated | relid=0 | w=20
- TAG --
r_associated #0: 15 / 0.385 ->
en:Tafeen's catheter
n1=TAG | n2=en:Tafeen's catheter | rel=r_associated | relid=0 | w=15
- TAG --
r_associated #0: 15 / 0.385 ->
entreprises
n1=TAG | n2=entreprises | rel=r_associated | relid=0 | w=15
- TAG --
r_associated #0: 15 / 0.385 ->
monde de l'entreprise
n1=TAG | n2=monde de l'entreprise | rel=r_associated | relid=0 | w=15
- TAG --
r_associated #0: 9 / 0.231 ->
entreprise
n1=TAG | n2=entreprise | rel=r_associated | relid=0 | w=9
- TAG --
r_associated #0: 9 / 0.231 ->
entreprise
(société)
n1=TAG | n2=entreprise (société) | rel=r_associated | relid=0 | w=9
- TAG --
r_associated #0: 1 / 0.026 ->
marque commerciale
n1=TAG | n2=marque commerciale | rel=r_associated | relid=0 | w=1
| ≈ 26 relations entrantes
- triglycérides ---
r_associated #0: 60 -->
TAG
n1=triglycérides | n2=TAG | rel=r_associated | relid=0 | w=60
- en:triglycerides ---
r_associated #0: 57 -->
TAG
n1=en:triglycerides | n2=TAG | rel=r_associated | relid=0 | w=57
- TAG-Porsche ---
r_associated #0: 52 -->
TAG
n1=TAG-Porsche | n2=TAG | rel=r_associated | relid=0 | w=52
- Tafeen (cathéter de) ---
r_associated #0: 39 -->
TAG
n1=Tafeen (cathéter de) | n2=TAG | rel=r_associated | relid=0 | w=39
- en:Tafeen's catheter ---
r_associated #0: 36 -->
TAG
n1=en:Tafeen's catheter | n2=TAG | rel=r_associated | relid=0 | w=36
- Techniques d'Amplification Génique ---
r_associated #0: 35 -->
TAG
n1=Techniques d'Amplification Génique | n2=TAG | rel=r_associated | relid=0 | w=35
- techniques d'amplification génique ---
r_associated #0: 35 -->
TAG
n1=techniques d'amplification génique | n2=TAG | rel=r_associated | relid=0 | w=35
- triacylglycérides ---
r_associated #0: 31 -->
TAG
n1=triacylglycérides | n2=TAG | rel=r_associated | relid=0 | w=31
- triacylglycérols ---
r_associated #0: 29 -->
TAG
n1=triacylglycérols | n2=TAG | rel=r_associated | relid=0 | w=29
- en:GAD ---
r_associated #0: 28 -->
TAG
n1=en:GAD | n2=TAG | rel=r_associated | relid=0 | w=28
- en:triglyceride ---
r_associated #0: 27 -->
TAG
n1=en:triglyceride | n2=TAG | rel=r_associated | relid=0 | w=27
- McLaren-TAG ---
r_associated #0: 26 -->
TAG
n1=McLaren-TAG | n2=TAG | rel=r_associated | relid=0 | w=26
- en:nucleic acid amplification technique ---
r_associated #0: 25 -->
TAG
n1=en:nucleic acid amplification technique | n2=TAG | rel=r_associated | relid=0 | w=25
- trouble anxieux généralisé ---
r_associated #0: 21 -->
TAG
n1=trouble anxieux généralisé | n2=TAG | rel=r_associated | relid=0 | w=21
- glycérides ---
r_associated #0: 20 -->
TAG
n1=glycérides | n2=TAG | rel=r_associated | relid=0 | w=20
- Glycérides ---
r_associated #0: 10 -->
TAG
n1=Glycérides | n2=TAG | rel=r_associated | relid=0 | w=10
- Triglycérides ---
r_associated #0: 10 -->
TAG
n1=Triglycérides | n2=TAG | rel=r_associated | relid=0 | w=10
- Trouble anxieux généralisé ---
r_associated #0: 10 -->
TAG
n1=Trouble anxieux généralisé | n2=TAG | rel=r_associated | relid=0 | w=10
- en:free floating anxiety ---
r_associated #0: 10 -->
TAG
n1=en:free floating anxiety | n2=TAG | rel=r_associated | relid=0 | w=10
- en:glycerides ---
r_associated #0: 10 -->
TAG
n1=en:glycerides | n2=TAG | rel=r_associated | relid=0 | w=10
- taffazine ---
r_associated #0: 10 -->
TAG
n1=taffazine | n2=TAG | rel=r_associated | relid=0 | w=10
- tafénoquine ---
r_associated #0: 10 -->
TAG
n1=tafénoquine | n2=TAG | rel=r_associated | relid=0 | w=10
- TAG Group ---
r_associated #0: 6 -->
TAG
n1=TAG Group | n2=TAG | rel=r_associated | relid=0 | w=6
- M TAG ---
r_associated #0: 4 -->
TAG
n1=M TAG | n2=TAG | rel=r_associated | relid=0 | w=4
- TAG Porsche ---
r_associated #0: 2 -->
TAG
n1=TAG Porsche | n2=TAG | rel=r_associated | relid=0 | w=2
- grammaire de TAG ---
r_associated #0: 2 -->
TAG
n1=grammaire de TAG | n2=TAG | rel=r_associated | relid=0 | w=2
|